{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:43:14Z","timestamp":1793245394985,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.annonc.2021.08.1746","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T14:10:40Z","timestamp":1628691040000},"page":"1425-1433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility"],"prefix":"10.1016","volume":"32","author":[{"given":"I.M.","family":"Modlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.","family":"Filosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Frilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Malczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Toumpanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bodei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.E.","family":"\u00d6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.annonc.2021.08.1746_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/carcin\/21.3.517","article-title":"Molecular epidemiology: recent advances and future directions","volume":"21","author":"Perera","year":"2000","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.annonc.2021.08.1746_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.annonc.2021.08.1746_bib3","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S1470-2045(20)30323-5","article-title":"Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy","volume":"21","author":"Bodei","year":"2020","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.annonc.2021.08.1746_bib4","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S1470-2045(15)00186-2","article-title":"Consensus on biomarkers for neuroendocrine tumour disease","volume":"16","author":"Oberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annonc.2021.08.1746_bib5","doi-asserted-by":"crossref","unstructured":"Shah MH, Kulke MH, Goldner WS, et\u00a0al. NCCN Guidelines: Neuroendocrine and Adrenal Tumors, Version 3.2018-Sept 11. In. 2018;693-702. https:\/\/dx.doi.org\/10.6004\/jnccn.2018.0056.","DOI":"10.6004\/jnccn.2018.0056"},{"issue":"2","key":"10.1016\/j.annonc.2021.08.1746_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41574-020-00458-x","article-title":"Diagnostic and therapeutic advances in neuroendocrine tumours","volume":"17","author":"Caplin","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.annonc.2021.08.1746_bib7","doi-asserted-by":"crossref","first-page":"e63364","DOI":"10.1371\/journal.pone.0063364","article-title":"The Identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood","volume":"8","author":"Modlin","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.annonc.2021.08.1746_bib8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1159\/000509091","article-title":"Blood Molecular Genomic analysis predicts the disease course of GEP NET patients: a validation study of the predictive value of the NETest\u00ae","volume":"111","author":"van Treijen","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.annonc.2021.08.1746_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1634\/theoncologist.2017-0623","article-title":"Assessment of NETest clinical utility in a US registry-based study","volume":"24","author":"Liu","year":"2019","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.annonc.2021.08.1746_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.annonc.2019.11.003","article-title":"A\u00a0meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood","volume":"31","author":"Oberg","year":"2020","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.annonc.2021.08.1746_bib11","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1158\/1078-0432.CCR-17-3378","article-title":"Pan-cancer molecular classes transcending tumor lineage across 32 cancer types, multiple data platforms, and over 10,000 cases","volume":"24","author":"Chen","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.annonc.2021.08.1746_bib12","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.3748\/wjg.v19.i15.2348","article-title":"United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment","volume":"19","author":"Strosberg","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"9596","key":"10.1016\/j.annonc.2021.08.1746_bib13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.annonc.2021.08.1746_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.annonc.2021.08.1746_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000446025","article-title":"NET blood transcript analysis defines the crossing of the clinical rubicon: when stable disease becomes progressive","volume":"104","author":"Pavel","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.annonc.2021.08.1746_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ejcts\/ezx386","article-title":"The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumors (BPNET) and as a tool to evaluate surgical resection and disease progression","volume":"53","author":"Filosso","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11","key":"10.1016\/j.annonc.2021.08.1746_bib17","doi-asserted-by":"crossref","first-page":"E1437","DOI":"10.1210\/jc.2015-2792","article-title":"Circulating transcript analysis (NETest) in GEP-NETs treated with Somatostatin Analogs Defines Therapy","volume":"100","author":"Cwikla","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.annonc.2021.08.1746_bib18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.annonc.2021.08.1746_bib19","first-page":"1630","article-title":"Follow-up recommendations after curative resection of well-differentiated neuroendocrine tumours: review of current evidence and clinical practice","volume":"8","author":"Lamarca","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"14","key":"10.1016\/j.annonc.2021.08.1746_bib20","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/onc.2016.316","article-title":"Translational research in neuroendocrine tumors: pitfalls and opportunities","volume":"36","author":"Capdevila","year":"2017","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.annonc.2021.08.1746_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1210\/jc.2018-01804","article-title":"Blood mRNA measurement (NETest) for neuroendocrine tumor diagnosis of image-negative liver metastatic disease","volume":"104","author":"Malczewska","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.annonc.2021.08.1746_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000508106","article-title":"Prospective evaluation of the NETest as a liquid biopsy for gastroenteropancreatic and bronchopulmonary neuroendocrine tumours: an ENETS centre of excellence experience neuroendocrinology","volume":"111","author":"Malczewska","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"34","key":"10.1016\/j.annonc.2021.08.1746_bib23","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.2174\/1381612822666160513145924","article-title":"Systems medicine approaches to improving understanding, treatment, and clinical management of neuroendocrine prostate cancer","volume":"22","author":"Yadav","year":"2016","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.annonc.2021.08.1746_bib24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1159\/000508573","article-title":"Neuroendocrine tumor omic gene cluster analysis amplifies the prognostic accuracy of the NETest","volume":"111","author":"Kidd","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"7","key":"10.1016\/j.annonc.2021.08.1746_bib25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00259-018-3967-6","article-title":"PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy","volume":"45","author":"Bodei","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.annonc.2021.08.1746_bib26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fendo.2018.00740","article-title":"Blood transcript profiling for the detection of neuroendocrine tumors: results of a large independent validation study","volume":"9","author":"van Treijen","year":"2018","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753421039752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753421039752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T06:07:12Z","timestamp":1760335632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753421039752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0923753421039752"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2021.08.1746","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2021.08.1746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society for Medical Oncology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}